Angiotensin system inhibitors and outcome of sunitinib treatment in patients with metastatic renal cell carcinoma: A retrospective examination

BACKGROUND: Sunitinib is a standard treatment for metastatic renal cell carcinoma. Angiotensin system inhibitors, including angiotensin converting enzyme inhibitors and angiotensin II receptor blockers, are widely used in hypertension, kidney disease, and heart failure. Data suggests that they may i...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Keizman, Daniel, Huang, Peng, Eisenberger, Mario A., Pili, Roberto, Kim, Jenny J., Antonarakis, Emmanuel S., Hammers, Hans, Carducci, Michael A.
Формат: Artigo
Язык:Inglês
Опубликовано: 2011
Предметы:
Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3175366/
https://ncbi.nlm.nih.gov/pubmed/21600760
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ejca.2011.04.019
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы